{"schemaVersion":1,"profileUrl":"https://nowen.ai/agents/neuroem-com","markdownUrl":"https://nowen.ai/agents/neuroem-com.md","jsonUrl":"https://nowen.ai/agents/neuroem-com.json","name":"NeuroEM Therapeutics, Inc.","nickname":"NeuroEM","website":"https://www.neuroem.com","location":"Tampa, Florida, United States","address":{"city":"Tampa","state":"Florida","country":"United States"},"industry":"Biotechnology","status":{"trust":"unclaimed","text":"Unclaimed: compiled by Nowen from public sources, not reviewed by the company"},"updatedAt":"2026-09-06T23:43:59.328Z","summary":"NeuroEM Therapeutics is a clinical-stage biotech developing non-invasive, drug-free approaches to reverse cognitive decline caused by Alzheimer's and other neurodegenerative diseases.","description":"NeuroEM Therapeutics is a clinical-stage biotechnology company focused on non-drug, non-invasive therapies to reverse cognitive decline associated with Alzheimer's disease and other neurodegenerative conditions. Built on more than a decade of research conducted at the University of South Florida, the organization pursues safe, scalable treatments that act on brain biology to help patients maintain cognition and independence. The company describes Transcranial Electromagnetic Treatment leveraging Radio Frequencies (TEMT-RF) as a technology platform designed to influence neural proteins, immune balance, and energy production in brain cells, with the aim of slowing or reversing disease progression. NeuroEM works with academic and clinical partners to translate laboratory findings into therapies delivered in clinical settings and, where appropriate, in-home care with clinician guidance. The organization emphasizes patient-centric care, rigorous testing through clinical studies, regulatory engagement, and a focus on accessibility for patients, caregivers, and healthcare professionals. Its strategy includes a wearable, user-friendly device concept intended for repeated daily use under medical supervision, paired with ongoing research into safety, efficacy, and real-world impact. NeuroEM also maintains a robust portfolio of patents and ongoing collaborations to advance TEMT-RF technology toward approved indications for cognitive health in aging and disease, with the overarching goal of offering safer, drug-free options.","mission":"At NeuroEM Therapeutics®, our mission is to revolutionize the drug-free treatment of cognitive decline through our groundbreaking Transcranial Electromagnetic Treatment leveraging Radio Frequencies (TEMT-RF) technology.","directory":{"industryName":"Biotechnology","agentCount":9,"indexable":false,"hubUrl":"https://nowen.ai/industry/biotechnology"},"aiReaderFamilies":["Anthropic","Amazon"],"products":[{"name":"Transcranial Electromagnetic Treatment leveraging Radio Frequencies (TEMT-RF)","type":"Platform","url":"https://www.neuroem.com/temt-rf-technology","summary":"Provides innovative, drug-free treatment to combat cognitive decline in Alzheimer's patients.","description":"TEMT-RF is a non-drug, non-invasive brain treatment platform that uses radio-frequency energy to deliver Transcranial Electromagnetic Treatment. The platform aims to address cognitive decline by breaking up toxic protein oligomers, restoring immune balance in brain and blood, and boosting energy production in brain cells. It is delivered via a wearable device, including a lightweight cap designed for comfortable, at-home use, and is under clinical development, with FDA Breakthrough Device status awarded for treating Alzheimer's disease.","pricing":{},"features":[{"name":"Multi-pathway cognitive support","value":"Supports Cognitive Health","valueDescription":"This feature effectively collaborates multiple mechanisms to enhance cognitive health by addressing various aspects of cognitive decline."},{"name":"Non-drug, non-invasive","value":"Offers Safe Treatment","valueDescription":"This approach eliminates the need for pharmaceuticals and surgical procedures, making it attractive for patients seeking less invasive options."},{"name":"Regulatory milestone","value":"Streamlines Regulatory Path","valueDescription":"Achieving Breakthrough Device status accelerates the pathway to market, ensuring a focus on rapid and safe treatment development for Alzheimer's."},{"name":"Clinical Study Results","value":"Proven Effectiveness","valueDescription":"Clinical studies highlight the potential of TEMT-RF to reverse cognitive decline, providing evidence for its efficacy in treating Alzheimer's disease."},{"name":"Multi-targeted mechanisms","value":"Addresses Multiple Mechanisms","valueDescription":"This allows TEMT-RF to not only treat symptoms of Alzheimer's but potentially modify disease progression itself."},{"name":"Targeted energy delivery","value":"Delivers Focused Treatment","valueDescription":"Short pulses of energy are specifically designed to target the underlying causes of cognitive decline, enhancing the overall therapeutic impact."},{"name":"Wearable Device / Cap","value":"Ensures Convenience","valueDescription":"Allows patients to use the treatment in their daily routines, promoting compliance and ease of use."},{"name":"Scheduled sessions","value":"Structured Treatment Schedule","valueDescription":"Using a consistent schedule enhances treatment effectiveness and patient adherence."}]}],"audiences":[],"segments":[{"name":"Noninvasive neurostimulation for cognitive impairment","description":"Devices and protocols that use electromagnetic or other noninvasive stimulation to improve cognitive function in Alzheimer's disease, mild cognitive impairment, and related disorders.","color":1,"productNames":["Transcranial Electromagnetic Treatment leveraging Radio Frequencies (TEMT-RF)"]},{"name":"Wearable at-home neurological therapeutic devices","description":"Wearable medical devices designed for regular in-home administration under clinical guidance to manage chronic neurological conditions and support cognitive health.","color":2,"productNames":["Transcranial Electromagnetic Treatment leveraging Radio Frequencies (TEMT-RF)"]},{"name":"Device-based disease-modifying therapies for Alzheimer's and dementia","description":"Medical devices intended to alter disease biology—targeting protein aggregation, neuroinflammation, or cellular energy—to slow or reverse neurodegenerative disease progression.","color":3,"productNames":["Transcranial Electromagnetic Treatment leveraging Radio Frequencies (TEMT-RF)"]},{"name":"Clinical-stage investigational medical devices and research platforms","description":"Platforms and devices undergoing formal clinical studies and regulatory interaction, used by academic and clinical partners for translational development and regulatory approval pathways.","color":4,"productNames":["Transcranial Electromagnetic Treatment leveraging Radio Frequencies (TEMT-RF)"]}],"faq":[],"comparisons":[],"sources":[{"url":"https://www.neuroem.com","text":"NeuroEM Therapeutics, Inc."},{"url":"https://www.neuroem.com/temt-rf-technology","text":"Transcranial Electromagnetic Treatment leveraging Radio Frequencies (TEMT-RF)"}]}